1. A Bayesian adaptive randomized phase II multicenter trial of bevacizumab with or without vorinostat in adults with recurrent glioblastoma. Issue 10 (13th March 2020) Authors: Puduvalli, Vinay K; Wu, Jing; Yuan, Ying; Armstrong, Terri S; Vera, Elizabeth; Wu, Jimin; Xu, Jihong; Giglio, Pierre; Colman, Howard; Walbert, Tobias; Raizer, Jeffrey; Groves, Morris D; Tran, David; Iwamoto, Fabio; Avgeropoulos, Nicholas; Paleologos, Nina; Fink, Karen; Peereboom, David; Chamberla... Journal: Neuro-oncology Issue: Volume 22:Issue 10(2020) Page Start: 1505 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. ACTR-13. A BAYESIAN ADAPTIVE RANDOMIZED PHASE II TRIAL OF BEVACIZUMAB VERSUS BEVACIZUMAB PLUS VORINOSTAT IN ADULTS WITH RECURRENT GLIOBLASTOMA FINAL RESULTS. (5th November 2018) Authors: Puduvalli, Vinay; Wu, Jing; Yuan, Ying; Armstrong, Terri; Wu, Jimin; Giglio, Pierre; Xu, Jihong; Colman, Howard; Walbert, Tobias; Raizer, Jeffrey; Groves, Morris; Iwamoto, Fabio; Tran, David; Avgeropoulos, Nicholas; Paleologos, Nina; Fink, Karen; Peereboom, David; Chamberlain, Marc; Merrell, Ryan... Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. ACTR-32. NRG ONCOLOGY RTOG 1205: RANDOMIZED PHASE II TRIAL OF CONCURRENT BEVACIZUMAB AND RE-IRRADIATION VS. BEVACIZUMAB ALONE AS TREATMENT FOR RECURRENT GLIOBLASTOMA. (11th November 2019) Authors: Tsien, Christina; Pugh, Stephanie; Dicker, adam; Raizer, Jeffrey; Matuszak, Martha; Lallana, Enrico; Huang, Jiayi; algan, ozer; Taylor, Nicholas; Portelance, Lorraine; Villano, John; T Hamm, John; S Oh, Kevin; N Ali, Arif; Kim, Michelle; Lindhorst, Scott; Mehta, Minesh Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi20 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. ACTR-33. INFIGRATINIB (BGJ398) IN PATIENTS WITH RECURRENT GLIOMAS WITH FIBROBLAST GROWTH FACTOR RECEPTOR (FGFR) ALTERATIONS: A MULTICENTER PHASE II STUDY. (11th November 2019) Authors: Lassman, Andrew; Sepúlveda-Sánchez, Juan; Cloughesy, Timothy; Gil-Gil, Juan; Puduvalli, Vinay; Raizer, Jeffrey; De Vos, Filip; Wen, Patrick; Butowski, Nicholas; Clement, Paul; Groves, Morris; Belda-Iniesta, Cristobal; Steward, Keith; Rowsey, Steven; Ye, Yining; Roth, Patrick Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi20 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. ACTR-40. PHASE 2 SAFETY AND EFFICACY OF AR-67 (7-T-BUTYLDIMETHYLSILTYL-10-HYDROXYCAMPTOTHECIN) IN PATIENTS WITH RECURRENT GLIOBLASTOMA MULTIFORME (GBM) OR GLIOSARCOMA. (11th November 2019) Authors: Kumthekar, Priya; Raizer, Jeffrey; Cavaliere, Robert; Devoe, Craig; Jensen, Randy; Stieber, Volker; Runk, Tina; Grewal, Jai; Brownell, Elise; Zukiwski, Alex; Proniuk, Stefan; Arnold, Susanne; Vredenburgh, James Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Anticonvulsant prophylaxis and steroid use in adults with metastatic brain tumors: summary of SNO and ASCO endorsement of the Congress of Neurological Surgeons guidelines*. Issue 4 (18th March 2019) Authors: Chang, Susan M; Messersmith, Hans; Ahluwalia, Manmeet; Andrews, David; Brastianos, Priscilla K; Gaspar, Laurie E; Gatson, Na Tosha N; Jordan, Justin T; Khasraw, Mustafa; Lassman, Andrew B; Maues, Julia; Mrugala, Maciej; Raizer, Jeffrey; Schiff, David; Stevens, Glen; Sumrall, Ashley; Van den Bent,... Journal: Neuro-oncology Issue: Volume 21:Issue 4(2019) Page Start: 424 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. ATIM-02. TUMOR TREATING FIELDS IN COMBINATION WITH BEVACIZUMAB IN RECURRENT OR PROGRESSIVE MENINGIOMA IN A PHASE 2 STUDY. (5th November 2018) Authors: Kumthekar, Priya; Kruser, Tim; Sachev, Sean; Raizer, Jeffrey; Grimm, Sean; Dixit, Karen Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. ATIM-14. ALLIANCE A071101: A PHASE II RANDOMIZED TRIAL COMPARING THE EFFICACY OF HEAT SHOCK PROTEIN PEPTIDE COMPLEX-96 (HSPPC-96) VACCINE GIVEN WITH BEVACIZUMAB VERSUS BEVACIZUMAB ALONE IN THE TREATMENT OF SURGICALLY RESECTABLE RECURRENT GLIOBLASTOMA. (6th November 2017) Authors: Bloch, Orin; Shi, Qian; Anderson, S Keith; Knopp, Michael; Raizer, Jeffrey; Clarke, Jennifer; Waziri, Allen; Colman, Howard; Bruce, Jeffrey; Olson, Jeffrey J; Schwerkoske, John; Parsa, Andrew; Uhm, Joon; Kumthekar, Priya; Galanis, Evanthia; Parney, Ian Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi29 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Buparlisib plus carboplatin or lomustine in patients with recurrent glioblastoma: a phase Ib/II, open-label, multicentre, randomised study. Issue 4 (13th July 2020) Authors: Rosenthal, Mark; Clement, Paul M; Campone, Mario; Gil-Gil, Miguel J; DeGroot, John; Chinot, Olivier; Idbaih, Ahmed; Gan, Hui; Raizer, Jeffrey; Wen, Patrick Yung; Pineda, Estela; Donnet, Valerie; Mills, David; El-Hashimy, Mona; Mason, Warren Journal: ESMO open Issue: Volume 5:Issue 4(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. CLRM-01. MACHINE LEARNING TO UNCOVER SIGNATURES OF VULNERABILITY IN GLIOBLASTOMA UMBRELLA SIGNATURE TRIAL (GUST). (21st September 2021) Authors: Peng, Sen; Lee, Matthew; Tang, Nanyun; Ahluwalia, Manmeet; Fonkem, Ekokobe; Fink, Karen; Raizer, Jeffrey; Walker, Christopher; Dhruv, Harshil; Berens, Michael Journal: Neuro-oncology advances Issue: Volume 3(2021)Supplement 4 Page Start: iv1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗